Ayisha Jeter Joins Arcutis as Vice President of Market Access

WESTLAKE VILLAGE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Ayisha Jeter has joined the company as Vice President of Market Access.  In this new role, Ms. Jeter will be responsible for Arcutis’ access and reimbursement efforts as the Company prepares for the potential future commercialization of its product candidates.

Click to view original post